Position in AMGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$377,691
+$166,772 QoQ
Shares Held
1,043
+54.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#2,381
of 3,140 holders
Holding Since
Mar 2024
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fi3 FINANCIAL ADVISORS, LLC holds $6,620,183 across 8 Drug Manufacturers - General names. AMGN ranks #6 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
7,501 | $1,905,028 | |
| 2 | ABBV |
AbbVie Inc.
|
7,080 | $1,781,611 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
9,091 | $1,148,556 | |
| 4 | LLY |
ELI LILLY & Co
|
7,465 | $555,769 | |
| 5 | MRK |
Merck & Co., Inc.
|
3,478 | $446,923 | |
| 6 | AMGN |
Amgen Inc
This page
|
1,043 | $377,691 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,064 | $234,167 | |
| 8 | PFE |
Pfizer Inc
|
7,078 | $170,438 |
All Filings in AMGN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $377,691 | 1,043 | Shares | Sole | 2026-08-14 | |
| 2025-03-31 | $210,919 | 677 | Shares | Sole | 2025-05-09 | |
| 2024-09-30 | $218,136 | 677 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $215,590 | 690 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $187,366 | 659 | Shares | Sole | 2024-05-06 | |
| No filing history on record for this holder in this stock. | ||||||